Lexaria Bioscience Corp. (LEXX)
3.22
+0.30
(+10.27%)
USD |
NASDAQ |
Oct 27, 16:00
3.24
+0.02
(+0.62%)
After-Hours: 20:00
Lexaria Bioscience Cash from Operations (Quarterly) : -1.635M for May 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.635M |
| February 28, 2026 | -2.164M |
| November 30, 2025 | -0.9841M |
| August 31, 2025 | -2.642M |
| May 31, 2025 | -3.584M |
| February 28, 2025 | -1.498M |
| November 30, 2024 | -2.726M |
| August 31, 2024 | -1.892M |
| May 31, 2024 | -1.266M |
| February 29, 2024 | -0.6196M |
| November 30, 2023 | -1.182M |
| August 31, 2023 | |
| May 31, 2023 | -1.786M |
| February 28, 2023 | -1.228M |
| November 30, 2022 | -1.245M |
| August 31, 2022 | -1.177M |
| May 31, 2022 | -1.259M |
| February 28, 2022 | -1.277M |
| November 30, 2021 | -1.166M |
| August 31, 2021 | -1.079M |
| May 31, 2021 | -1.168M |
| February 28, 2021 | -0.9245M |
| November 30, 2020 | -0.8183M |
| August 31, 2020 | -0.6393M |
| May 31, 2020 | -0.6705M |
| Date | Value |
|---|---|
| February 29, 2020 | -0.7539M |
| November 30, 2019 | -0.5551M |
| August 31, 2019 | -0.7768M |
| May 31, 2019 | -1.101M |
| February 28, 2019 | -0.6033M |
| November 30, 2018 | -0.5643M |
| August 31, 2018 | -0.8358M |
| May 31, 2018 | -0.5632M |
| February 28, 2018 | -0.5814M |
| November 30, 2017 | -0.5026M |
| August 31, 2017 | -0.1147M |
| May 31, 2017 | -0.6035M |
| February 28, 2017 | -0.4881M |
| November 30, 2016 | -0.101M |
| August 31, 2016 | -0.2608M |
| May 31, 2016 | -0.1083M |
| February 29, 2016 | -0.0828M |
| November 30, 2015 | -0.209M |
| August 31, 2015 | -0.5809M |
| May 31, 2015 | -0.3861M |
| February 28, 2015 | -0.3609M |
| November 30, 2014 | -0.1732M |
| October 31, 2014 | |
| July 31, 2014 | -0.2229M |
| April 30, 2014 | -0.0969M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | -0.2229M |
| InMed Pharmaceuticals, Inc. | -2.909M |
| XORTX Therapeutics, Inc. | -3.250M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.53M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0271M |
| Free Cash Flow | -7.527M |
| Free Cash Flow Per Share (Quarterly) | -1.005 |
| Free Cash Flow to Equity (Quarterly) | -1.654M |
| Free Cash Flow to Firm (Quarterly) | -1.661M |
| Free Cash Flow Yield | -155.5% |